Skip to main content
XGN
NASDAQ Life Sciences

Exagen Posts 25-Cent Quarterly Loss as Diagnostics Firm's Results Land

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$7.59
Mkt Cap
$172M
52W Low
$2.59
52W High
$10.405
52W Position info
193% above low
Off High info
27% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

XGN has more than doubled off its 52-week low of $2.59 on elevated volume (2.0× avg).

Summary

Exagen reported a third-quarter loss of 25 cents a share on revenue of $18.4M, up 7% from a year earlier, with the net loss at $6.34M. That follows a Q2 in which revenue grew 15.9% to $19.9M and the net loss narrowed to $3.2M, with $24.6M of cash and a stated 12-month runway. The company reiterated 2026 revenue guidance of $72M-$75M. The loss lands against a thin cash cushion, which makes the pace of AVISE CTD volume and reimbursement the swing factor for how long the runway holds. Insider activity has been mixed: CEO John Aballi sold 34,294 shares at $7.87 in October to cover taxes on vesting RSUs, while 10% owner Jorey Chernett bought 14,000 shares at a weighted average of $7.46.

At the time of this announcement, XGN was trading at $7.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $172M. The 52-week trading range was $2.59 to $10.41. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

XGN - Latest Insights

XGN
Nov 10, 2026, 9:49 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.26
Real-time Price: $4.40 info
Change: -$0.860 (-16%) info
Market Cap: $112.515M info
XGN
Nov 10, 2026, 9:33 AM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $5.83
Real-time Price: $4.40 info
Change: -$1.43 (-25%) info
Market Cap: $112.515M info
XGN
Nov 10, 2026, 9:01 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.55
Real-time Price: $4.40 info
Change: -$2.15 (-33%) info
Market Cap: $112.515M info
XGN
Aug 04, 2026, 9:15 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.66
Real-time Price: $4.40 info
Change: -$1.26 (-22%) info
Market Cap: $112.515M info
XGN
Aug 04, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.60
Real-time Price: $4.40 info
Change: -$1.20 (-21%) info
Market Cap: $112.515M info